MGNX

Latest SEC Filings & News for MGNX

1 most recent filing and news item mentioning MGNX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/MGNX/news?limit=20"

Pull MGNX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJul 23, 2026Positive

MacroGenics advances MGC026 in Phase 1 study for squamous cell carcinoma of the head and neck

MacroGenics reports success in the Phase 1 Stage 1 cohort of MGC026 for squamous cell carcinoma of the head and neck and announced clinical trial poster presentations at ESMO 2026.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.